Meet MiniMed FlexTM
A fully connected, app-controlled pump and our smallest insulin pump yet. The MiniMed FlexTM system automatically adjust and corrects glucose levels continuously through the day and night for people living with diabetes.◊,1
Mealtimes – without the mental math.
Meal DetectionTM tech‡ helps to keep glucose levels in range — even if they’re not a perfect carb counter or sometimes forget to bolus.§,◊,¶
Safely treats to a low glucose target of 100 mg/dL without increasing hypoglycemia when using recommended settings.◊,#.
Use of recommended settings when using the SmartGuardTM feature yields the highest Time in Range.
80% Time in Range seen worldwide¶
Recommended settings of 100 mg/dL and 2 hr AIT have shown consistent results globally.2 Real-world results∆ in adults showed patients achieved up to 80% Time in Range with recommended settings¶ without increasing hypoglycemia.3
System components
MiniMed Flex insulin pump
MiniMed Flex insulin pump
Features Meal DetectionTM technology§ which anticipates, adjusts and corrects◊ every 5 minutes - now in a small, sleeker design, about 50% smaller,†† and can be fully controlled through the MiniMedTM app.
User data is conveniently stored within both the pump and app.
Continuous glucose monitors (CGM)
Continuous glucose monitors (CGM)
Flexibility to choose between two sensor options that continuously monitors your glucose levels and works seamlessly with the Flex insulin pump.
Instinct sensor — A small, discreet3 and comfortable4 to wear sensor that lasts up to 15 days.
Simplera SyncTM sensor — An all-in-one disposable sensor giving you a once-a-week change with up to 6 days of wear, plus 24-hour grace period.
ExtendedTM infusion set and reservoir
ExtendedTM infusion set and reservoir
Featuring a 300 unit reservoir — With only one set change per week, they can experience 96% fewer injections compared to multiple daily injections.‡‡
Other infusion sets available.
MiniMedTM app
MiniMedTM app
Displays glucose levels, pump information, and TIR data on compatible smartphones.◊◊ Provides notifications for highs and lows. Compatible with both iOS and Android devices.
CareLinkTM Clinic
CareLinkTM Clinic
9 out of 10 HCPs surveyed agreed CareLinkTM Clinic reports are the best-in-class for treatment of patients on automated insulin delivery (AID) therapy.##
Life with flexibility for people with diabetes
More time for sleep
Fewer beeps and alarms with up to 90.7% overnight Time in Range∆,∞,#,7 as seen in real world results.
No technology experience? No problem!
79.8% Time in Range achieved for people with T2D despite 63% of participants in the T2D pivotal trial not having prior technology experience including either an insulin pump or CGM system.7
In phase 2, participants achieved 84.9% TIR.∆,#,7
Fewer changes. More freedom
Using the ExtendedTM Infusion set and Simplera SyncTM sensor plan for weekly changes vs. 3-4 per week with other AID systems.‡‡
Technical specifications
Size and weight
- Size: 3.8 inches length x 1.0 inches width x 1.4 inches depth
- Weight: 73 grams (without consumables)
Compatible insulin
The MiniMed Flex system is intended for use with the following compatible U-100 insulins:
- U-100 AdmelogTM*
- U-100 HumalogTM*
- U-100 NovoLogTM*
- U-100 FiaspTM*
- U-100 LyumjevTM*
Waterproof capabilities
The MiniMed Flex pump is waterproof up to 8 feet (2.4 meters) for 1 hour and 45 minutes (105 minutes) if you choose to stay connected while in water.
Environmental conditions
The FlexTM 780G pump system is designed to withstand most conditions encountered in your daily life. Pump operating temperature range is from 41°F to 93°F (5°C to 34°C). Pump storage temperature range is from -4°F (-20°C) to 122°F (50°C). Storing the pump in temperatures outside of this range can damage the pump.
Altitude range
- Storage range: 10.2 psiA to 15.4 psiA
- Pump operating range: 10.2 psiA to 15.4 psiA
Bolus delivery
The pump delivers small doses of insulin. The smallest dose of insulin is 0.05 units.
Increments
- 0.1 units (default)
- 0.01
Max bolus 25 units
Basal rate delivery
Minimum basal insulin increment: 0.050 units/hour.
Above 0.050, increments can be set in 0.025-unit increments (e.g., 0.05, 0.075, 0.1, etc.).
Max basal 15 units
Battery and power
The pump uses a wall charger. It takes approximately 30 minutes for a full charge, and a full charge will last at least 7 days.
Warranty
Insulin pump: 4 years standard. Some insurances allow up to 5 years (see your insurance details to confirm).
Compatible
products
Reservoir
ExtendedTM Reservoir MMT-342, 10PK. 3.0 ml (300 units)
Infusion sets
MiniMed offers a wide range of infusion sets so that you can choose the right one for your comfort and safety.
Continuous glucose monitor
Instinct sensor, made by Abbott
Simplera SyncTM sensor
Accessories
There are many ways to wear your insulin pump. You can attach your pump to your waistband or belt, protect it in your pocket, or even clip it under clothing.
Trusted insulin automation, now in a more compact size.
Powered by the same proven algorithm within the MiniMedTM 780G system that helps protect against highs without increasing lows, MiniMed Flex offers a small, sleek design controlled from an app.
CGM alone is not enough - ADAPT Study
Download
Footnotes
† Due to inherent analysis limitations, caution is advised when attempting to extrapolate these results to new patients (and different populations and ages). There could be significant differences. Study weaknesses include a relatively small sample size and exclusion criteria for those with limited carb counting skills.
‡ Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.
§ Taking a bolus 15 - 20 minutes before a meal helps to keep blood sugar levels under control after eating.
◊ Refers to SmartGuardTM feature. Individual results may vary.
¶ Carb entry still required.
# The SmartGuardTM feature in the MiniMed Flex is equivalent to the MiniMed 780G system.
Δ Due to inherent real-world data limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences.
∞ Overnight period: 12:00 A.M. - 6:00 A.M. Number of users with ≥10 days of sensor glucose data; Optimal settings are glucose target at 100 mg/dL (5.5 mmol/L) and Active Insulin Time (AIT) at 2 hours and used >95% of the time.
†† Pump dimensions on File - IFU Labeling. Overall size related to volume in comparison with MiniMed 780G.
‡‡ Based on usage of 4 Simplera Sync sensors for 6 days each and 4 Extended Infusion Sets for 7 days each in a one month period. More insertions may be required if Simplera Sync sensor or Extended infusion set requires replacement before specified wear time.
§§ Fingersticks required in manual mode & to enter SmartGuardTM. If symptoms don’t match alerts & readings, use a fingerstick. Refer to user guide.
◊◊ For a list of compatible devices, visit bit.ly/CheckDevices.
¶¶ Based on usage of 4 Simplera Sync sensors for 6 days each and 4 Extended Infusion Sets for 7 days each in a one-month period. More insertions may be required if Simplera Sync sensor or Extended infusion set requires replacement before specified wear time.
## Medtronic Diabetes: CareLinkTM Clinic Market Research Survey, n=379; Q1 2025; P. 9-10 (February 2025)
References
- Choudhary P, et al. Lancet Diabetes Endocrinol. 2022;10(10):720-731.
- McVean JJF, Niu F, Liu M, et al. Automated insulin delivery with the MiniMedTM 780G system reduces burden by improving sleep and glycaemic control overnight. Diabetes Obes Metab. 2026;28(3):2456-2460. doi:10.1111/dom.70380
- Arrieta A, et al. Diabetes Obes Metab. 2022;10.1111/dom.14714
- Data on File, Abbott Diabetes Care, Inc.
- Alva, Shridhara, Ronald Brazg, Kristin Castorino, Mark Kipnes, David R. Liljenquist, and Hanqing Liu. "Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System." Diabetes Therapy 14, no. 4 (2023): 767-776. https://doi.org/10.1007/s13300-023-01385-6
- Data on file, CIP330 Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics.
- Bhargava A, Bergenstal RM, Warren ML, et al. Safety and Effectiveness of MiniMedTM 780G Advanced Hybrid Closed-Loop Insulin Intensification in Adults with Insulin-Requiring Type 2 Diabetes. Diabetes Technol Ther. 2025;27(5):366-375. doi:10.1089/dia.2024.0586
- Bhargava A., et al. Diabetes Technol & Ther. 2025;27(5):366-375. https://dx.doi.org/10.1089/dia.2024.0586 2. MiniMedTM 780G Insulin Pump System User Guide. Medtronic 2026
Important Safety Information: MiniMed FlexTM system with SmartGuardTM technology with Simplera SyncTM sensor and Instinct sensor
The MiniMed FlexTM system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin.
The MiniMed FlexTM system includes SmartGuardTM technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera SyncTM sensor and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.
WARNING: Do not use the SmartGuardTM feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuardTM feature.
WARNING: Do not use the MiniMedTM Flex system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMedTM Flex system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuardTM feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed FlexTM system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including user guides and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, see https://link.minimed.com/Risks.
©2026 Medtronic MiniMed, Inc. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. TM*Third–party brands are trademarks of their respective owners.